기술과 전략
Saving Lives with Innovative Cancer Vaccine Technologies

항암 백신 치료전략

항암백신 타겟 항원 선정

난치암 바이러스 항원
(Viral antigen)
  • Virus-derived proteins
  • Safe and promising targets for immunotherapy:
  • Absent from any non-infected tissue
  • Highly immunogenic
  • Not subject to immune escape
  • Viral oncoantigen target
    - HPV+ cancers
    - EBV+ cancers
암 연관 항원
(Tumor associated antigen)
  • Tumor associated antigens (TAA)
  • Tumor shared antigens (TSA)
  • Overexpressed and mutant antigens
  • Prostate cancers
  • CTA (cancer testis antigens)
  • Oncofetal antigens
난치암 신생 항원
(Neoantigen)
  • Antigens derived from sequence-altered (mutated) proteins
  • Promising targets for cancer immunotherapy
  • Drive highly specific activation of the immune system (recognized as foreign)
  • Exempt from central tolerance
  • Mutant neoantigens for individualized neoantigens specific immunotherapy

항암백신 병용 최적화